FERRARA PIETRO

Zamagni, G., Carreras, G., Armocida, B., Gakidou, E., Ashbaugh, C., Alicandro, G., et al. (2026). National and subnational burden of disease attributable to risk factors in Italy, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023. THE LANCET PUBLIC HEALTH, 11(5), 293-305 [10.1016/S2468-2667(26)00048-4]. Dettaglio

Antonazzo, I., Fornari, C., Buongarzone, G., Ferrara, P., Crotti, G., Zucchi, A., et al. (2026). Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study. EPILEPSIA, 67(2), 686-695 [10.1111/epi.18706]. Dettaglio

Geraci, G., Paternò, V., Vitello, A., Maida, M., Bonomo, F., Sanfilippo, S., et al. (2026). Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction–associated steatotic liver disease. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION [10.1007/s40618-026-02908-1]. Dettaglio

Oh, J., Kim, S., Yim, Y., Kim, M., Zyoud, S., Zyoud, S., et al. (2026). Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study. NATURE MEDICINE, 32(1), 197-223 [10.1038/s41591-025-04077-9]. Dettaglio

Gona, P., Estrada‑martinez, L., Zhang, L., Gona, C., Mody, A., Rao, S., et al. (2026). Correction: Racial disparity in mortality from tuberculosis in the US between states with and without a history of Jim‑Crow laws: an analysis of the Global Burden of Disease (GBD) and risk factors study, 1990 to 2019 [Altro] [10.1186/s12889-025-26090-w]. Dettaglio